Skip to main content

Westhampton Capital, LLC

SEC CIK
0001639997
Latest filing
Jul 14, 2026

REGN holding history

Regeneron Pharmaceuticals, Inc. in every 13F filed by Westhampton Capital, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

REGN overviewAll 13F holders of REGNFull Q2 2026 holdings

Shares (Q2 2026)
1,238
Value
$771.9K
% of portfolio
0.3%
Quarters held
22
Since Q1 2021
Holdings of REGN by Westhampton Capital, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20261,238$771.9K0.3%+15+1.2%AddedHolders
Q1 20261,223$944.9K0.4%00.0%UnchangedHolders
Q4 20251,223$944.0K0.4%+40+3.4%AddedHolders
Q3 20251,183$665.2K0.3%+56+5.0%AddedHolders
Q2 20251,127$591.7K0.3%+42+3.9%AddedHolders
Q1 20251,085$688.1K0.4%+22+2.1%AddedHolders
Q4 20241,063$757.2K0.4%+170+19.0%AddedHolders
Q3 2024893$938.8K0.5%+15+1.7%AddedHolders
Q2 2024878$922.8K0.5%00.0%UnchangedHolders
Q1 2024878$845.1K0.5%+15+1.7%AddedHolders
Q4 2023863$758.0K0.5%00.0%UnchangedHolders
Q3 2023863$710.2K0.5%00.0%UnchangedHolders
Q2 2023863$620.1K0.4%+20+2.4%AddedHolders
Q1 2023843$692.7K0.4%00.0%UnchangedHolders
Q4 2022843$608.2K0.4%+22+2.7%AddedHolders
Q3 2022821$566.0K0.4%00.0%UnchangedHolders
Q2 2022821$485.0K0.3%+3+0.4%AddedHolders
Q1 2022818$571.0K0.4%00.0%UnchangedHolders
Q4 2021818$517.0K0.3%00.0%UnchangedHolders
Q3 2021818$495.0K0.3%00.0%UnchangedHolders
Q2 2021818$457.0K0.3%+20+2.5%AddedHolders
Q1 2021798$378.0K0.3%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.